Awareness of Osteoporosis in Multiple Sclerosis Patients

Uskudar State Hospital

Status: Completed

Conditions: Osteoporosis; Osteoporosis Risk; Multiple Sclerosis

Treatments: Diagnostic Test: Timed up - and - go test; Other: Patient Participation Form

Study type: Observational

Funder types: Other

Identifiers

NCT05760651

OPMS1

Details and patient eligibility

About

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Multiple sclerosis patients are at increased risk for developing osteoporosis. Identifying whether multiple sclerosis patients have information and awareness about this disease is crucial. This study is aimed to investigate awareness and knowledge of osteoporosis in multiple sclerosis (MS) patients. The study also aimed to assess potential differences and correlations in osteoporosis knowledge and awareness among MS patients based on gender, education levels, and risk of falls

Full description

Osteoporosis is a common disease of bone loss. The reduced bone strength predisposes an increased risk for fractures in older individuals. It can affect people from different ethnicity. Many factors increase the risk of osteoporosis, including age, postmenopausal state, glucocorticoid use, low body weight, calcium, vitamin D, immobility, and chronic inflammation. Patients with multiple sclerosis are at high risk of developing osteoporosis due to chronic inflammation and their medications. Patients' knowledge and awareness about osteoporosis are essential for early detection, implementation of lifestyle changes, and treatment compliance. This study aimed to investigate osteoporosis awareness and knowledge about osteoporosis in patients with multiple sclerosis.The study also aimed to assess potential differences and correlations in osteoporosis knowledge and awareness among MS patients based on gender, education levels, and risk of falls

Enrollment: 325 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of multiple sclerosis
• Must be between the ages of 18 and 99
• Must give consent to participate in the study

Exclusion criteria

• Not giving consent

Trial design

325 participants in 1 patient group

Multiple Sclerosis Patients

Description:

Patients diagnosed with multiple sclerosis.

Treatment:

Other: Patient Participation Form

Diagnostic Test: Timed up - and - go test